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Abstract
In Portugal there is a mixed system in matters concerning the national blood service. The rea-
sons for such state of things are both historical and cultural nevertheless the system has been 
evolving since its early days from a fully-hospital-based form to the present mixed-system form. 
The increase in the number of blood collections/donations which has contributed to self-
sufficiency in red cell and platelet components/products is the outcome of the strategies/policies 
described in this article. The activity of blood donor associations has been playing a crucial role 
in this process with its typical liaison to the community and citizens differentially motivated 
to donate blood as well as partnership with health structures involved in Blood Establishment 
(BE) activities.
Since 2012, the recently merged Portuguese Blood and Transplant Institute (by Decree 
No.39/2012 published in February) has launched some novel and more radical community 
communication strategies in order to recruit new donors mainly from the population of young 
people as well as donors who had already donated blood but only once. This change constitutes 
a modification in the communication with donors and with the prospective donors within the 
population. 
The participation of Hospital Blood Establishments (BE)/Services in the national blood trans-
fusion service is also undergoing important changes with emphasis being now put on blood col-
lection “linked” to the 3 Blood and Transplant Centres of the Portuguese Blood and Transplant 
Institute (PBTI) where the screening, processing and distribution is performed allowing blood 
donors to continue their “donation story” within hospital premises. 
Portugal has been evolving with good outcomes in what the national blood service is concerned 
and the current perspectives are to invest and continue in the pursuit of self sufficiency in blood, 
blood components and derivatives along with gains in efficiency within this direction at the 
country level.
J. Transf. Med. 2014; 7: 2–9
Introduction
In terms of national policies regarding organi-
zation of what is usually referred to as “national 
blood service”, i.e. the organization of blood do-
nation and transfusion services, there are many 
different approaches to be seen in European coun-
tries and the differences are observed even among 
European Union member states. 
Since 2002 the European Commission/Parlia-
ment has issued several directives referring to the 
quality and safety of blood (2002/98/CE; 2004/33/
CE; 2005/61/CE and 2005/62/CE). These direc-
tives covered the most relevant aspects related to 
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blood and blood components and the purpose was 
to establish a common framework and to facilitate 
free movement of people and goods within the 
boundaries of the EU. 
Among the numerous definitions enclosed 
in the “mother directive” there is that of a ‘blood 
establishment’. Based on this definition a blood 
establishment (BE) is a structure or body respon-
sible for the interaction with the community and 
prospective blood donors, organization of blood 
collection as well as processing, storage and distri-
bution of blood components. Its counterpart is the 
hospital transfusion service which is closer to the 
patient (de facto the prospective recipient of blood 
components), and responsible for the subsequent 
elements of the blood transfusion chain until the 
moment of administration of the blood component 
to the recipient following compatibility testing 
along with hemovigilance procedures. 
In some countries the organization of blood 
transfusion service follows centralised patterns 
and systems. An example of such system is found 
in the United Kingdom (UK) where the institutions 
in charge of what is now defined as BE, have been 
separate from hospitals responsible for administra-
tion of “blood” to patients since the middle of last 
century. In some other countries the system is 
entirely hospital-based-BE, in the same premises 
where the hospital transfusion service with the 
transfusion medicine responsibilities is located. In 
others (like in Portugal) the system evolved from 
this hospital-based-BE system to a mixed-organi-
zation form in which some hospitals perform only 
services related to transfusion medicine practice, 
that take place in hospital transfusion services, 
others have both BE plus transfusion medicine 
practice responsibilities and there is also the Por-
tuguese Blood and Transplant Institute (PBTI) with 
its BE responsibilities accounting for around 60% 
of the country blood collection.
PBTI assignments encompass not only “blood” 
responsibilities but also the field of cell, tissue and 
organ transplantation, as prescribed by the reor-
ganization of the central structure of the State and 
Public Administration. The year 2011 witnessed 
the publication of the Reduction and Improve-
ment Plan of the Central State Administration 
(PREMAC) to be implemented across the whole 
Public Administration. This document declares the 
intention to “eliminate overlapping structures in 
the state structure, reducing the number of agen-
cies and entities, keeping quality in public service 
delivery”. This has proved quite effective particu-
larly in the field of health organization as presented 
in Figure 1 (2000) and Figure 2 (2010) showing the 
schematic reorganization of Primary Healthcare 
structures, the nowadays Secondary Healthcare 
focus being in Hospital Centres resulting from 
the fusion of 2 or more hospitals and primary care 
structures instead of the former type of organiza-
tion based on hospitals separated from each other 
and from the primary care structures. 
The Portuguese Blood Institute (PBI) was cre-
ated in 1989 with 3 regional Blood Centres (Porto, 
Coimbra and Lisbon) covering the continental 
country. The fusion of PBI with the previously 
Figure 1. National Health Service Network (ACSS/Central Administration of the Health System) in 2000
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existing and fully independent from each other 
3 Histocompatibility Centres located in the same 
cities as the Blood Centres and dedicated to the 
laboratory support to organ, cells and tissue trans-
plantation including the takeover of some functions 
of the Authority for Blood and Transplantation 
Services was therefore made by order of superior 
authority. This merger which was published in 2012 
to become effective in August 2012, was made of-
ficial in January 2013. The many processes entailed 
will most predictably take 2 to 3 years to become 
stabilised. This merger also means that the PBTI 
takes over the responsibilities of the Portuguese 
Bone Marrow Donors Registry (CEDACE), the Mul-
tiorganic Tissue Bank, the Public Cord Blood Bank 
and histocompatibility testing to support cell, tissue 
and solid organ transplantation as well as regulatory 
responsibilities in blood and transplantation areas.
Figure 3. Distribution of blood establishments in Portugal (the mainland and the islands)
Figure 2. National Health Service Network (ACSS/Central Administration of the Health System) in 2010
Portuguese Blood System
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Portugal is a European country situated on the 
south western tip of the Iberian Peninsula (Figure 3) 
with a total area of  92 090 km². It comprises the 
mainland and two autonomous regions constituted 
by the Azores and Madeira archipelagos in the 
Atlantic Ocean. According to the last 2011 census 
the population of Portugal was 10 561 614 and 
has remained fairly stable over the years. The 
persistently low birth rates in the last 2 decades 
however provide imbalance between the older 
and the younger population and signal difficulties 
in maintaining donor population (typically below 
65 years of age) in the near future. It is therefore pre - 
dictable that there will be consequences for blood 
collection and blood supply as it is well recognised 
that the demands in transfusion support increase 
in the elder population. 
History
The beginnings of blood banks or blood trans-
fusion services in Portugal date back to early 1920s. 
They were first organized in the main hospitals 
of the 2 major cities (Lisbon and Porto) and in 
the following decades in almost each and every 
existing hospital because of the donor-recipient 
proximity and in most cases as family or replace-
ment donation. About 30 years later, in 1958, the 
National Blood Institute (NBI) was established by 
the Decree Law 41495 of 2 January 1958 published 
in the Portuguese Official Journal with the aim to: 
“Coordinate, guide and supervise [...] activities 
related to collection, preparation and delivery of 
blood as a therapeutic agent [...], blood collection, 
preparation, storage and distribution”, “promotion 
of voluntary blood donation”, “staff training”. 
The established goals were not fully accom-
plished particularly as regards blood collection. 
These blood service activities were performed in 
most hospitals in Portugal. Instead the NBI main fo-
cus was on educational and laboratory development 
fulfilling an important part of the needs in this field.
In the meantime, very important develop-
ments were going on in education. In 1981 trans-
fusion medicine was recognized and introduced 
as a specialty (Imunohemoterapia) for medical 
doctors and a year later it was applied in practice. 
The 60-month curriculum followed the “model 
curriculum for the training of specialists in blood 
transfusion”, Recommendation R (85)5 of the Coun-
cil of Europe. Those were the years which brought 
about a new threat to blood safety due to the newly 
identified HTLV-III (HIV-1), the diagnosed cases of 
transmission through blood and the AIDS epidemic. 
The challenge to all “blood systems” and health 
professionals in this field was serious as no blood 
tests were then available and blood safety relied 
upon strict donor information, implementation of 
risky-behavior-questionnaire and straightforward-
ness of donors who supplied the data on their 
risky behavior. The same applied to HIV-2 (1986) 
and HCV (1989) although in the case of these two 
viruses the pharmaceutical industry reacted more 
promptly by bringing approved tests on the market. 
Implementation of a blood policy more appro-
priate for the country’s needs, requires a vision and 
Figure 4. Blood collection in Portugal
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political decision which have to be based on correct 
diagnosis. In Portugal such diagnosis was made in 
the late 1980s and covered several issues i.e. the 
number of blood services, blood collection, screen-
ing tests applied and the type of blood components 
among other information. 
Following this diagnosis, the Portuguese 
Blood Institute (PBI) (Law 25/1989; Decree Law 
294/1990) was established with 3 Regional Blood 
Centres. The purpose was to “plan, coordinate, 
direct, supervise at the national level […] activities 
[…] to promote blood donation, procurement, prepa - 
 ration, quality control, storage, distribution and ad-
ministration of blood”. In other words, the aim of the 
PBI was to implement a blood service at a national 
level and to work towards self sufficiency in blood 
components as well as to comply with the needs to 
inform the population about everyday demand for 
blood, to promote blood donation, to organize (at 
a national level) the activities of collection and pro-
cessing of blood to be distributed to hospitals. In the 
legal document it was clearly stated that “collected 
blood is a gift to the community […] not susceptible 
of compensation”, emphasizing the voluntary non 
remunerated blood donation and including the issue 
of penalties in cases of non compliance. In those days 
blood collection at the national level was far below 
the standard of blood self-sufficiency (Figure 4). 
Luckily, specialists in transfusion medicine were 
already working in all the hospital clinical fields, 
namely in consultancy activities towards the other 
medical specialty areas, facilitating the supply of 
blood components to patients in need.
The years 1990 and 2000
Through the WHO Resolution WHA28.72 
adopted in 1975, the world assembly encouraged 
the General Director to assist member states in the 
organization of national blood transfusion services, 
because “it is necessary to have blood components 
produced in services solidly implanted and with 
high technicality” in order to respond to transfu-
sion needs (Gestion des Services de Transfusion 
Sanguine, OMS, Geneve).
The disadvantages of small blood services 
have been identified and include among others high 
blood component losses due to expiry, misuse of 
economic resources and dispersion of skilled hu-
man resources. The need for a national blood pro-
gram was therefore recognized in order to imple-
ment and supervise the organization and the legal 
regulations related to this area of activity if blood 
sufficiency was to be achieved and high standards 
of quality and management of financial resources 
were to be assured.
Self-sufficiency in blood and blood components 
has two main branches: one is at the collection side 
in interaction with the community where the PBI 
BE attributions and actions fit best; the other is at 
the hospital side in close contact with the patient, 
prospective transfusion-recipient where the major 
goal is optimization of blood use and transfusion 
safety. This is the field of action for the hospital 
transfusion service. The role of transfusion medi-
cine (TM) specialist is crucial in both these cases. 
Fortunately in the 1990s we already had country 
coverage by TM specialists that were being trained 
since 1982. 
These two branches need to be brought to-
gether through a relationship between blood cent-
ers and hospital transfusion services. Such network 
has to be built to secure the best possible outcome 
within the national blood transfusion network 
which will further facilitate optimal management 
of blood components within the country along with 
reducing the losses due to expiry. 
Collection, processing and testing
In 1990 the statistics for blood collection were 
as follows: 203 042 units of blood: 24 265 (12%) 
collected by the PBI (2 Regional Blood Centres) 
and 178 777 (88%) collected by the 92 Hospital 
Blood Services) [Ministry of Health data]. One 
of the crucial aspects of blood policy defined at 
the time was to discontinue collection, process-
ing and analytical screening of blood donated 
in hospital blood services of reduced capacity. 
Those functions were transferred to the PBI 
Regional Blood Centers. 
The goal was not easy to accomplish. From 
the hospital perspective there was the expected 
resistance towards change as well as the fear of 
losing blood donors and becoming dependent on 
PBI for blood components. There was also the 
anxiety that the supply of blood components may 
be insufficient. The process of evolution in blood 
collection demonstrates the progress in reaching 
blood sufficiency and shows how difficult it was 
to build. At the same time residual blood collec-
tion by private entities was gradually eliminated 
(Figure 4). 
We may judge by the increasing volume of col-
lected blood that there was large donation capacity 
in the community and citizens could donate blood 
through the PBI blood mobiles that covered almost 
the whole territory of our country. Although the 
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number of hospitals with blood service/BE was 
decreasing, their overall blood collection capacity 
was maintained due to the proximity link between 
blood donors and hospitals.
In the meantime, haemovigilance programs 
were being implemented and blood component 
bacterial contamination was gaining importance at 
an international level. In 1997 screening of platelet 
concentrates for bacterial contamination was first 
implemented in the PBI as an important measure 
for blood and blood component safety. 
The eruption of Bovine Serum Encephalopa-
thy (BSE) and the anxiety that the abnormal prion 
could be transmitted through blood gave rise to 
a series of decisions, namely the implementation 
in 1998 of universal prestorage leukodepletion of 
blood components. 
Buffy coat derived platelets processing was 
subject to optimization in the early 2000 which 
led the way for the validation of the first pathogen 
reduction technology (Intercept Platelet) in 2004. 
This technology was first used in Lisbon Regional 
Blood Centre, and started being distributed to 
hospitals some time later (in 2010). 
Another important issue was the encourage-
ment to hospital BE/Blood Services not to go 
forward in performing Nucleic Acid Testing (NAT) 
screening of blood units collected. That function 
would be assumed by the PBI, either along with 
transmissible agents serology or not. Systematic 
NAT screening started in January 2003 in one of the 
Regional Blood Centers and the growing concerns 
related to efficiency lead to an increasing number 
of blood services to send their samples to PBI 
for screening. In 2006 an automated NAT testing 
covering the 3 Viruses (HIV, HCV and HBV) was 
implemented.
Hemovigilance
The beginnings of Portuguese Hemovigilance 
System date back to 1997 and were introduced by 
the PBI; the decision to assign professionals to the 
coordination and work on the dedicated software 
was made in 1998. The model was defined in co-
operation with physicians/TM specialists and other 
health professionals from the PBI and hospital 
blood services throughout the country. 
In 2007 two important legal documents were 
published in the Portuguese Official Journal. One 
was the Decree Law 267/2007 that transposed the 
European Union directives on quality and safety 
of blood (2002/98/CE; 2004/33/CE; 2005/61/CE; 
2005/62/CE) into the Portuguese legal order and 
the other Decree 67/2007 established the compe-
tent authority for Blood and Transplantation Ser-
vices as required by EU directives. The Portuguese 
Hemovigilance System, created by the PBI in the 
late 1990s was immediately prepared to fulfill the 
requirements of Directive 2005/61/CE and Decree 
Law 267/2007. In 2008 the notifications from 2007 
and 2008 could already be reported to the EU. On 
the other hand, Quality Management Systems were 
already implemented and duly certified in PBI and 
most Hospital Blood Services. Establishment of 
the Competent Authority contributed to marked 
advancement in the organization of the blood sys-
tem in Portugal. 
There are several tools and actions recom-
mended at the international level for more effective 
management of blood components, particularly 
related to reduction of losses due to expiry, in 
close relationship with the transfusion medicine 
specialists and their clinical advisory roles within 
the hospitals. These tools include such moves as 
organization of hospital transfusion committees, 
teams of health professionals, i.e. doctors of differ-
ent medical specialties working together in order to 
define guidelines and implement the best practice. 
In 1999 certain proactive measures were taken at 
the main regional health administration level (on 
which hospitals are dependent) which encouraged 
hospital administrations to organize and maintain 
hospital transfusion committees for optimal use 
of blood and blood components. The results were 
promising. 
Plasma
Once the blood policy was defined and oriented 
towards blood self sufficiency and development of 
a more effective blood collection system and bet-
ter correlation of related fields of activity, more 
attention could now be paid to self-sufficiency in 
“plasma” matters. 
The first objective was to secure supplies 
of fresh frozen plasma (FFP) inactivated with 
the only method known at that time, namely the 
Octapharma solvent detergent (SD) technique. 
Unfortunately, the eruption of bovine serum en-
cephalopathy (BSE) and the suspicion that the 
abnormal prion could be transmitted through 
blood gave rise to a series of decisions namely 
the implementation of universal prestorage leu-
kodepletion of blood components. In 1998 Portugal 
was one of the first countries to implement such 
measures. The context of BSE control led to the 
ban of Portuguese beef on the international market. 
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This fact as well as the dramatic UK situation with 
human variant Creutfeldt Jacob disease (nvCJD) 
cases, diagnosed one after another followed by the 
decision not to use their own FFP had immediate 
impact on the sequence of events in Portugal; the 
“plasma” program was stopped and postponed until 
epidemiological evidence and control of eventual 
nvCJD cases proved it safe enough to be continued. 
In the meantime, other approaches to pathogen re-
duction and inactivation were being developed and 
the scope of action covered also other pathogens 
besides those targeted by the SD method.
Quarantine FFP (QFFP) was then imple-
mented enabling its clinical use for transfusion 
along with SD Plasma supplied by Octapharma 
(7635 QFFP units and 50958 SD Plasma units 
respectively — 2012 national data). 
After 2010
Before March 2011, each of the 3 PBI Re-
gional Blood Centers fitted in the definition of 
Blood Establishments according to the EU Di-
rectives. They comprised all activities from col-
lection, screening, processing to distribution. 
The year 2011 witnessed the implementation of 
measures introduced to concentrate sites which 
perform analytical screening of donations (from 
3 to 2 locations); quality control of production 
(from 3 to 1) and processing (from 3 to 2). Further-
more, standardization of medical devices for blood 
collection began and brought about positive results 
at the level of purchase with scale effects because 
of the overall cost reductions. 
Of great organizational impact were the chang-
es in both theoretical and practical training, as well 
as evaluation and qualification of health profes-
sionals for clinical screening of donors and blood 
collection. The changes which had such significant 
impact on the institution consisted in the inclusion 
also of nurses in clinical screening of donors. The 
model in place until then was based on doctors 
only. The change became stabilized in the course of 
2012 and blood collection sessions always include 
1 doctor. Laboratory technicians started being 
trained to collect blood units that were previously 
only collected by nurses. Blood collection sessions 
always include nurses.
Some decisions regarding blood screening 
were also made. ALT testing was discontinued. 
The HTLV-I/II tests previously performed for 
each and every donation started to be performed 
in the first donation as well as in special situations. 
In reference to malaria, the tests for donor candi-
dates were introduced in 2012 as replacement for 
quarantine. This allowed PBTI to recover some 
donor candidates.
As stated above platelet concentrates subjec-
ted to pathogen inactivation (pathogen reduction 
technology with Intercept Platelet) started being 
distributed to hospitals at the end of 2010 although 
not for the whole platelet production. 
The tendency towards concentration of BE 
processes in the PBTI leaves place to former 
hospital BEs to maintain the function of blood 
collection in proximity with donors. Thus it was 
decided that some hospitals could maintain blood 
collection with a new approach. Medical devices 
for blood collection are distributed by the PBTI 
and there are two possible options: one is that 
PBTI health professionals are given access to 
hospital premises, the other that blood collec-
tion is performed by their own trained hospital 
health professionals. In the latter case hospitals 
are reimbursed per blood unit collected at a price 
published in the Official Journal. In both situa-
tions whole blood units are sent to the PBTI for 
analytical screening and processing. 
As stated above, the Decree 39/2012 published 
in 2012 established the Portuguese Blood and 
Transplant Institute IP with 3 Blood and Transplant 
Centres (in Lisbon, Coimbra and Porto). The areas 
of blood (former PBI with Regional Blood Centres) 
and transplantation (former independent 3 His-
tocompatibility Centres) were thus combined. In 
relation to blood collection capacity, PBTI performs 
about 60% of the country blood collection and cov-
ers all geographical regions in the continental part 
of Portugal. 
Last year the PBTI Executive Board went for-
ward with some immediate, totally new and more 
radical strategies of communicating with the com-
munity for new donor recruitment mainly from the 
young population as well as for recruitment of do-
nors who had donated blood only once. A call/con-
tact center was established and is being expanded 
in order to stay in touch with donors from our files. 
This innovation brought about an important change 
in the methods of communication and promotion of 
blood donation and the results are truly promising. 
In 2013 a mobile phone application for bidirectional 
performance management (Android, iOS, FB, web 
“www.dador.pt”) was developed to impact mainly 
in the younger population with information on the 
needs for blood components and places were blood 
sessions are taking place. Other strategies include 
a thorough dissemination of daily blood donation 
needs (Hospitals, Health Centres, etc.) parallel to 
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the advertising annual donation campaign with high 
impact on the population between 18 and 35 years 
(stress on membership and loyalty). 
In what the Portuguese plasma program is con-
cerned, with the stabilization of the blood collection 
and the national situation of vCJD cumulative cases 
that are in line with a great majority of European 
Countries, measures are under development with 
the goal of providing hospitals, in the shortest pos-
sible time with FFP inactivated by two different 
methodologies; one is amotosalen treated plasma 
produced by the same blood centre that performs 
the procedure with platelets and the other is SD 
Plasma subject to treatment by the manufacturer 
— Octapharma). The surplus of FFP is intended as 
raw material for the manufacture of plasma derived 
medicinal products subject to open competition 
outside the PBTI IP.
Conclusions
The major impact of the blood policies im-
plemented before 1989/1990 was brought about 
by the decision to create a new medical specialty 
in transfusion medicine (Imunohemoterapia) with 
emphasis on the prolongation of training time and 
scope. Specialists in transfusion medicine were 
employed in blood centres and in hospital blood 
services and/or transfusion medicine services 
since 1987. 
From 1989/1990 onwards, the focus was on 
implementation of specific measures for estab-
lishing and organization of an effective “National” 
Blood Service, directed at self sufficiency in blood 
and blood components which would adhere to the 
state of the art regarding technologic and scientific 
areas and organizational trends.
Since 2012 we have been facing a new chal-
lenge brought about by the initiative for reorgani-
zation of the Portuguese Public Administration 
sector namely by the Ministry of Health New 
Organic Law which was applied to the whole 
health structure and redefined it. Opportunity was 
created for a vast and deep change in the structure 
of the health care system (Hospitals and Primary 
Health Care) that is being currently rebuilt with 
the reorganization of Primary Healthcare struc-
tures, the nowadays Secondary Healthcare focus 
being in Hospital Centres resulting from the 
fusion of 2 or more hospitals and primary care 
structures instead of the former type of organiza-
tion based in hospitals separated from each other 
and from the primary care structures. The same 
applies to the PBTI and has great impact on it. 
As regards the policy for concentration of blood 
collection sites we may say that although not yet 
fully implemented it is approaching its goal and 
the current situation is almost in reverse to that 
which existed twenty years back (88% of blood was 
collected in 92 hospital blood bank services, 12% 
was collected by PBI while in 2012, 40% of blood 
is collected by 30 hospital BE and 60% by PBTI).
As regards to sufficiency in blood and blood 
components, the effects of the 20 year effort are 
as follows: from less than 20 blood units per 1000 
inhabitants collected in 1990 we reached the level 
of 39 units per 1000 inhabitants in 2011 and 
38 units per 1000 inhabitants in 2012.
As presented above, the internal restructuring 
of the system of blood collection, processing and 
analytical screening, along with the consolidation of 
the many previously existing quality management 
systems into one quality management system ap-
plied to the PBTI as a whole as well as standardiza-
tion of procedures and devices will result in cost 
savings that can be expected to increase in the 
process of further restructurization along with 
the processes associated with the transplantation 
functions and responsibilities. 
Regardless of the type of organization or the 
direction in which this field of medicine evolves, 
we must keep in mind the issue of the major impor-
tance, which is the safety and care of blood donors 
and blood component recipients. In this respect 
cooperation and effective communication has an 
important role to play and should bring together 
all professionals involved. 
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